Titlebook: Carcinoma of the Bladder; Innovations in Manag Zbigniew Petrovich (Professor and Chairman),Luc Ba Book 1998 Springer-Verlag Berlin Heidelbe

拼圖游戲

書目名稱Carcinoma of the Bladder影響因子(影響力)




書目名稱Carcinoma of the Bladder影響因子(影響力)學(xué)科排名




書目名稱Carcinoma of the Bladder網(wǎng)絡(luò)公開度




書目名稱Carcinoma of the Bladder網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Carcinoma of the Bladder被引頻次




書目名稱Carcinoma of the Bladder被引頻次學(xué)科排名




書目名稱Carcinoma of the Bladder年度引用




書目名稱Carcinoma of the Bladder年度引用學(xué)科排名




書目名稱Carcinoma of the Bladder讀者反饋




書目名稱Carcinoma of the Bladder讀者反饋學(xué)科排名

昏睡中

Prognostic Factors in Bladder Cancer: Emphasis on Immunohistochemical Analysis,among all genitourinary tumors. In 1996, it is estimated that 52900 new cases of the disease will be diagnosed, with 11 700 of these patients projected to die from the disease (. et al. 1996). Approximately 80% of patients with primary bladder cancer present with low-grade tumors confined to the sup

Feedback

scoliosis

deriver

Imaging Modalities in the Diagnosis and Staging of Carcinoma of the Bladder,nsidered a basic imaging study in patients with a suspected bladder neoplasm. The rationale for the use of IVU is to exclude upper tract disease. A diagnosis of multicentric synchronous neoplasm is of major importance since it will change patient management. Urothelial neoplasms of the upper tract a

支柱

支柱

Staging of Bladder Cancer,present with muscle-invasive cancer (T2, T3-4, N+, M+) (. et al. 1992). History, physical examination, urine cytology, intravenous pyelography, and endoscopy, together with adequate tissue sampling by transurethral resection (TUR), are considered to be the cornerstones of the diagnostic armamentariu

食品室

減去

Fluorescence Detection of Bladder Cancer,s, such as cystitis (bacterial, chemical, or due to radiotherapy), are often invisible to the naked eye. Therefore, biopsies have to be taken for determination of histopathology. Unfortunately, a biopsy represents only a small sample area, and the final pathology results are available only after sev

mortuary

Treatment of Ta, T1 Bladder Tumors: Recent Results of the EORTC-GU Group,versy. Transurethral resection (TUR) remains the treatment of choice, but there is a considerable risk of recurrence of tumors thus treated (50%–70%), as well as a lower risk (10%–15%) of progression to muscle-invasive disease (. et al. 1995). Adjuvant treatment has been advocated for 30 years in or